CXCL10 靶点蛋白|抗体药物|临床药物信息

CXCL10信息

英文名称：C-X-C motif chemokine ligand 10
中文名称：C-X-C基序趋化因子配体10
靶点别称：Protein 10 From Interferon (Gamma)-Induced Cell Line，CXCL10，INP10，SCYB10，C-X-C motif chemokine 10，10 kDa interferon gamma-induced protein，IP-10，C-X-C Motif Chemokine Ligand 10，Small Inducible Cytokine Subfamily B (Cys-X-Cys)， Member 10，Chemokine (C-X-C Motif) Ligand 10，Small-Inducible Cytokine B10，Chemokine CXCL10，Interferon-Inducible Cytokine IP-10，Gamma IP10，Gamma-IP10，GIP-10，IFI10，Crg-2，Mob-1，C7

上市药物数量：0
临床药物数量：2
最高研发阶段：临床二期

CXCL10产品列表

筛选结果

产品库

在研 (1)

物种

Human (1)

标签

His Tag (1)

属性

Protein (1)

标记

Unconjugated (1)

货号	物种	产品描述	蛋白结构	纯度	活性
CX0-H51H1	Human	Human CXCL10 / IP-10 Protein, His Tag

CXCL10 分子别名

C-X-C motif chemokine 10,10 kDa interferon gamma-induced protein,Gamma-IP10,IP-10,Small-inducible cytokine B10,CXCL10(1-73),CXCL10,INP10, SCYB10

CXCL10 分子背景

C-X-C Motif Chemokine Ligand 10 (CXCL10) is a pro-inflammatory chemokine secreted by a wide spectrum of cells. It is involved in multiple mechanisms and reported to have pleiotropic effects, including immune cell migration and attraction to inflammation sites, angiogenesis, and cancer cell growth. CXCL10 is produced by pancreatic islet cells upon inflammatory stress and is specifically recognized by C-X-C Motif Chemokine Receptor 3 (CXCR3) which is expressed by activated T-lymphocytes and other immune cells.

CXCL10 前沿进展

CXCL10临床药物信息

英文名称	研发代码	研发阶段	公司	适应症	临床试验
NG-641	NG-641; NG-aFAP; EnAd-FAP-Tac; EnAd-FAP-BiTE	临床一期	牛津大学, Psioxus Therapeutics Ltd	头颈部鳞状细胞癌, 腺性和上皮性肿瘤, 转移癌	详情
JT-02 (JYANT Technologies)	JT-02	临床二期	Jyant Technologies	炎症性肠疾病	详情

会议日历

会议一览

CXCL10